I. Salti, E. Bénard, and B. Detournay, A Population-Based Study of Diabetes and Its Characteristics During the Fasting Month of Ramadan in 13 Countries: Results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study, EPIDIAR) study, pp.2306-2311, 1422.
DOI : 10.2337/diacare.27.10.2306

M. Al-abouj, S. Assaad-khalil, and J. Buse, Recommendations for management of diabetes during Ramadan, Update Diabetes Care, vol.33, pp.1895-1902, 2010.

P. Zimmet, K. Alberti, and J. Shaw, Global and societal implications of the diabetes epidemic Fasting in religion Available from : http://altreligion.about.com/od, Nature, vol.4145, pp.782-787, 2001.

B. Sadeghirad, S. Motaghipisheh, and F. Kolahdooz, Islamic fasting and weight loss: a systematic review and meta-analysis, Public Health Nutrition, vol.24, issue.02, pp.396-406, 2012.
DOI : 10.1038/sj.ejcn.1602393

C. Colette and L. Monnier, Di??t??tique des ??tats diab??tiques, pp.91-107, 2014.
DOI : 10.1016/B978-2-294-70868-8.50006-2

R. Havel, Caloric Homeostasis and Disorders of Fuel Transport, New England Journal of Medicine, vol.287, issue.23, pp.1186-1192, 1972.
DOI : 10.1056/NEJM197212072872307

R. Defronzo, Pathogenesis of type 2 diabetes :metabolic and molecular implications for identifying diabetes genes, Diabetes Rev, vol.5, pp.177-269, 1997.

N. Lessan, Z. Hannoun, and H. Hasan, Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: Insights from continuous glucose monitoring (CGM), Diabetes & Metabolism, vol.41, issue.1, pp.28-36, 2015.
DOI : 10.1016/j.diabet.2014.11.004

L. Monnier, A. Wojtusciszyn, and C. C. , The Contribution of Glucose Variability to Asymptomatic Hypoglycemia in Persons with Type 2 Diabetes, Diabetes Technology & Therapeutics, vol.13, issue.8, pp.813-818, 2011.
DOI : 10.1089/dia.2011.0049

S. Ezzat and M. Amin, Energy intake, dietary pattern and physical activity during the holy month of Ramadan and their impact on body weight, Int J Food Nutr Public Health, vol.6, pp.291-309, 2013.

B. Bakhotmah, The puzzle of self-reported weight gain in a month of fasting (Ramadan) among a cohort of Saudi families in Jeddah, Western Saudi Arabia, Nutrition Journal, vol.51, issue.2, pp.84-91, 2011.
DOI : 10.1080/096374800100822

D. Sachs, Measurement of Hemoglobin A1c: A new twist on the path to harmony, Diabetes Care, vol.35, issue.12, pp.2674-2680, 2012.
DOI : 10.2337/dc12-1348

T. Lyons and A. Jenkins, Glycation, oxidation and lipoxidation in the development of the complications of diabetes : a carbonyl stress hypothesis, Diabetes Rev, vol.5, pp.365-391, 1997.

M. Brownlee, Biochemistry and molecular cell biology of diabetic complications, Nature, vol.414, issue.6865, pp.813-820, 2001.
DOI : 10.1038/414813a

R. Holman, S. Paul, and M. Bethel, 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes, New England Journal of Medicine, vol.359, issue.15, pp.1577-1589, 2008.
DOI : 10.1056/NEJMoa0806470

L. Monnier, F. Bonnet, and C. C. , New insights on glucose homoeostasis during Ramadan, Diabetes & Metabolism, vol.41, issue.1, pp.1-4, 2015.
DOI : 10.1016/j.diabet.2014.11.005

URL : https://hal.archives-ouvertes.fr/hal-01146929

S. Dinneen, J. Gerich, and R. Rizza, Carbohydrate metabolism in non-insulin dependent diabetes mellitus, N Engl J Med, vol.327, pp.707-713, 1992.

L. Monnier, Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes?, European Journal of Clinical Investigation, vol.48, issue.3, pp.3-11, 2000.
DOI : 10.1002/(SICI)1096-9136(199808)15:8<657::AID-DIA652>3.0.CO;2-7

C. Cobelli, A. Mari, and E. Ferrannini, Non-steady state : error analysis of Steele's model and development for glucose kinetics, Am J Physiol (Endocrinol Metab), vol.252, pp.679-689, 1987.

K. Kausbal and S. Raina, "Risk approach strategy" in diabetics on fasting-evidence base through narrative review with a special focus on Ramadan fasting, Journal of Social Health and Diabetes, vol.3, issue.1, pp.11-15, 2015.
DOI : 10.4103/2321-0656.140876

J. Alkaabi, B. Al-dabbagh, and S. Ahmad, Glycemic indices of five varieties of dates in healthy and diabetic subjects, Nutrition Journal, vol.114, issue.10, p.59, 2011.
DOI : 10.1002/ijc.20796

K. Foster-powell, S. Holt, and J. Brand-miller, International table of glycaemic index and glycaemic load value 2002, Am J Clin Nutr, vol.76, pp.5-56, 2002.

S. Heymsfield, J. Harp, and M. Reitman, Why do obese patients not lose more weight when treated with low-caloric diets ? A mechanistic perspective

B. El-aziz, S. Skalli, and A. Chadli, Diabète et Ramadan : mise au point sur les recommandations récentes, Méd mal Métabol, vol.8, pp.221-225, 2014.

K. Cusi and R. Defronzo, Metformin : a review of its metabolic effects, Diabetes Rev, vol.6, pp.89-131, 1998.

D. Drucker and M. Nauck, The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes, The Lancet, vol.368, issue.9548, pp.1696-1705, 2006.
DOI : 10.1016/S0140-6736(06)69705-5

D. Owens, L. Monnier, and G. Bolli, Differential effects of GLP-1 receptor agonists on components of dysglycaemia in individuals with type 2 diabetes mellitus, Diabetes & Metabolism, vol.39, issue.6, pp.485-496, 2013.
DOI : 10.1016/j.diabet.2013.09.004

H. Lebovitz, Alphaglucosidase inhibitors as agents in the treatment of diabetes, Diabetes Rev, vol.6, pp.132-145, 1998.

C. Bailey, Renal glucose reabsorption inhibitors to treat diabetes, Trends in Pharmacological Sciences, vol.32, issue.2, pp.63-71, 2011.
DOI : 10.1016/j.tips.2010.11.011

P. Gourdy, Effets ind??sirables et s??curit?? d???emploi des inhibiteurs des SGLT2, M??decine des Maladies M??taboliques, vol.9, issue.1, pp.41-48
DOI : 10.1016/S1957-2557(15)30056-0

S. Halimi and B. Vergès, Adverse effects and safety of SGLT-2 inhibitors, Diabetes & Metabolism, vol.40, issue.6, pp.28-34, 2014.
DOI : 10.1016/S1262-3636(14)72693-X

H. Lebovitz, Insulin secretagogues : old and new, Diabetes Rev, vol.7, pp.139-153, 1999.

L. Monnier, C. C. Dunseath, and G. , The Loss of Postprandial Glycemic Control Precedes Stepwise Deterioration of Fasting With Worsening Diabetes, Diabetes Care, vol.30, issue.2, pp.263-269, 2007.
DOI : 10.2337/dc06-1612

G. Boden, X. Chen, and J. Urbain, Evidence for a Circadian Rhythm of Insulin Sensitivity in Patients With NIDDM Caused by Cyclic Changes in Hepatic Glucose Production, Diabetes, vol.45, issue.8, pp.1044-1050, 1996.
DOI : 10.2337/diab.45.8.1044

L. Monnier, C. C. Sardinoux, and M. , Frequency and Severity of the Dawn Phenomenon in Type 2 Diabetes: Relationship to age, Diabetes Care, vol.35, issue.12, pp.2597-2599, 2012.
DOI : 10.2337/dc12-0385

L. Monnier, C. C. Dejager, and S. , Magnitude of the Dawn Phenomenon and Its Impact on the Overall Glucose Exposure in Type 2 Diabetes: Is this of concern?, Diabetes Care, vol.36, issue.12, pp.4057-4062, 2013.
DOI : 10.2337/dc12-2127

L. Monnier, C. C. Dejager, and S. , The dawn phenomenon in type 2 diabetes: How to assess it in clinical practice?, Diabetes & Metabolism, vol.41, issue.2, pp.132-137, 2015.
DOI : 10.1016/j.diabet.2014.10.002